0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

From
EUR$4,490USDGBP
From
EUR$5,850USDGBP
Ceftriaxone - Global Strategic Business Report - Product Thumbnail Image

Ceftriaxone - Global Strategic Business Report

  • Report
  • June 2025
  • 281 Pages
  • Global
From
EUR$5,850USDGBP
Ascorbic Acid - Global Strategic Business Report - Product Thumbnail Image

Ascorbic Acid - Global Strategic Business Report

  • Report
  • June 2025
  • 194 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Nocturia Drugs - Global Strategic Business Report - Product Thumbnail Image

Nocturia Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 192 Pages
  • Global
From
EUR$5,850USDGBP
Genitourinary Drugs - Global Strategic Business Report - Product Thumbnail Image

Genitourinary Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 194 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Diuretic Drugs - Global Strategic Business Report - Product Thumbnail Image

Diuretic Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 372 Pages
  • Global
From
EUR$5,850USDGBP
Desmopressin - Global Strategic Business Report - Product Thumbnail Image

Desmopressin - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
EUR$5,850USDGBP
Male Urinary Incontinence - Global Strategic Business Report - Product Thumbnail Image

Male Urinary Incontinence - Global Strategic Business Report

  • Report
  • June 2025
  • 563 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Uropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Uropathy Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 67 Pages
  • Global
From
EUR$5,850USDGBP
Dimethyl Sulfoxide (DMSO) - Global Strategic Business Report - Product Thumbnail Image

Dimethyl Sulfoxide (DMSO) - Global Strategic Business Report

  • Report
  • June 2025
  • 258 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$3,850USDGBP
From
EUR$3,250USDGBP
EUR$4,850USDGBP
Sodium Bicarbonate - Global Strategic Business Report - Product Thumbnail Image

Sodium Bicarbonate - Global Strategic Business Report

  • Report
  • June 2025
  • 402 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$5,850USDGBP
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more